How to buy Exicure stock
Learn how to easily invest in Exicure stock.
Exicure is a biotechnology business based in the US. Exicure shares (XCUR) are listed on the NASDAQ and all prices are listed in US Dollars. Exicure employs 7 staff and has a trailing 12-month revenue of around $23.8 million.
How to buy Exicure stock
- Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – XCUR. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 in stock when you fund a new account within 30 days
- Easy to use platform with $0 stock trading & no annual fees
- Social trading allows you to copy popular portfolios
- FINDER EXCLUSIVE: Guaranteed $15 bonus when you sign up and deposit $100
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $100 - $2,000 when you open and fund an account with $5,000 to $100,000+
Exicure stock price (NASDAQ: XCUR)Use our graph to track the performance of XCUR stocks over time.
Exicure shares at a glance
|Latest market close||$0.74|
|52-week range||$0.63 - $1.96|
|50-day moving average||$1.02|
|200-day moving average||$1.08|
|Wall St. target price||$2.00|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$1.73|
Buy Exicure stock from these online trading platformsCompare special offers, low fees and a wide range of investment options among top trading platforms.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Is it a good time to buy Exicure stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Exicure price performance over time
|1 week (2023-09-15)||-20.43%|
|1 month (2023-08-22)||-9.42%|
|3 months (2023-06-22)||-39.34%|
|6 months (2023-03-22)||-24.87%|
|1 year (2022-09-22)||-52.56%|
|2 years (2021-09-22)||-42.19%|
|3 years (2020-09-22)||1.92|
|5 years (2018-09-21)||4.93|
Is Exicure stock undervalued or overvalued?
Valuing Exicure stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Exicure's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Exicure's P/E ratio
Exicure's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 1x. In other words, Exicure shares trade at around 1x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Exicure's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $4.3 million.
The EBITDA is a measure of a Exicure's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$23.8 million|
|Operating margin TTM||13.49%|
|Gross profit TTM||$9.1 million|
|Return on assets TTM||7.36%|
|Return on equity TTM||56.4%|
|Market Capitalization||$7.9 million|
TTM: trailing 12 months
Exicure share dividends
We're not expecting Exicure to pay a dividend over the next 12 months.
Have Exicure's shares ever split?
Exicure's shares were split on a 1:30 basis on 29 June 2022. So if you had owned 30 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Exicure shares – just the quantity. However, indirectly, the new 2900% higher share price could have impacted the market appetite for Exicure shares which in turn could have impacted Exicure's share price.
Exicure share price volatility
Over the last 12 months, Exicure's shares have ranged in value from as little as $0.63 up to $1.96. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Exicure's is 1.1309. This would suggest that Exicure's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Exicure, Inc. , an early-stage biotechnology company, develops nucleic acid therapies targeting ribonucleic acid against validated targets. The company's preclinical candidate includes SCN9A that is in preclinical studies for the treatment of chronic pain. It also develops immuno-oncology therapeutics based on its proprietary SNA technology. Exicure, Inc. was founded in 2011 and is headquartered in Chicago, Illinois. .
Frequently asked questionsWhat percentage of Exicure is owned by insiders or institutions?
Currently 90.237% of Exicure shares are held by insiders and 10.935% by institutions. How many people work for Exicure?
Latest data suggests 7 work at Exicure. When does the fiscal year end for Exicure?
Exicure's fiscal year ends in December. Where is Exicure based?
Exicure's address is: 2430 North Halsted Street, Chicago, IL, United States, 60614 What is Exicure's ISIN number?
Exicure's international securities identification number is: US30205M1018 What is Exicure's CUSIP number?
Exicure's Committee on Uniform Securities Identification Procedures number is: 30205M101
More guides on Finder
How to buy Discord stock when it goes public
Everything we know about the Discord IPO, plus information on how to buy in.
Today’s trending Reddit stocks
We’ve pulled a list together of the meme stocks being mentioned most on Reddit in the past 24 hours.
How to buy Tottenham Acquisition I stock
Steps to owning and managing TOTA, with 24-hour and historical pricing before you buy.
How to buy TotalEnergies stock
Steps to owning and managing TOT, with 24-hour and historical pricing before you buy.
How to buy Thunder Bridge Acquisition stock
Steps to owning and managing THBR, with 24-hour and historical pricing before you buy.
How to buy Switchback Energy Acquisition Corporation stock
Steps to owning and managing SBE, with 24-hour and historical pricing before you buy.
How to buy Telefonica SA ADR stock
Steps to owning and managing TEF, with 24-hour and historical pricing before you buy.
How to buy Faraday Future stock
Steps to owning and managing PSACU, with 24-hour and historical pricing before you buy.
How to buy Phoenix Tree stock
Steps to owning and managing DNK, with 24-hour and historical pricing before you buy.
How to buy Innate Pharma stock
Steps to owning and managing IPHA, with 24-hour and historical pricing before you buy.
Ask an Expert